![](/img/cover-not-exists.png)
PRO79 EVALUATING REAL LIFE CRITERIA THAT COULD DRIVE PRICING & REIMBURSEMENT (P&R) APPROVAL OF ORPHAN DRUGS (ODS) IN SPAIN
Badia, F.J., Poveda, J.L., Tort, M., Tania, V., Shepherd, J.Volume:
22
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.09.2409
Date:
November, 2019
File:
PDF, 383 KB
2019